Pulmonary aspergillosis  by Chabi, M.L. et al.
Diagnostic and Interventional Imaging (2015) 96, 435—442
REVIEW /Thoracic imaging
Pulmonary  aspergillosis
M.L.  Chabia,∗,  A.  Goraccib,  N.  Rochec,  A.  Paugamd,
A. Lupoe,  M.P.  Revel f
a Service  de  radiologie  polyvalente  et  oncologique,  groupe  hospitalier  de  la  Pitié-Salpêtrière
— Charles-Foix,  AP—HP,  83,  boulevard  de  l’Hôpital,  75651  Paris  cedex  13,  France
b Département  d’imagerie  médicale,  service  de  radiologie,  IRCCS  Istituto  Clinico  Humanitas,
Via Manzoni  56,  20089  Rozzano,  Italy
c Service  de  pneumologie,  hôpital  d’instruction  des  armées  du  Val-de-Grâce,  74,  boulevard  de
Port-Royal, 75230  Paris  cedex  05,  France
d Service  de  parasitologie-mycologie-médecine  tropicale,  hôpital  Cochin,  27,  rue  du
Faubourg-Saint-Jacques,  75679  Paris  cedex  14,  France
e Service  d’anatomie  et  de  cytologie  pathologiques,  hôpital  Cochin,  27,  rue  du
Faubourg-Saint-Jacques,  75679  Paris  cedex  14,  France
f Service  de  radiologie  A,  hôpital  Cochin,  27,  rue  du  Faubourg-Saint-Jacques,  75679  Paris
cedex 14,  France
KEYWORDS
Aspergillosis;
Lung  infections;
Computed
tomography
Abstract  Aspergillosis  is  a  mycotic  disease  usually  caused  by  Aspergillus  fumigatus,  a  sapro-
phytic and  ubiquitous  airborne  fungus.  Aspergillus-related  lung  diseases  are  traditionally
classiﬁed  into  four  different  forms,  whose  occurrence  depends  on  the  immunologic  status  of  the
host and  the  existence  of  an  underlying  lung  disease.  Allergic  broncho-pulmonary  aspergillo-
sis (ABPA)  affects  patients  with  asthma  or  cystic  ﬁbrosis.  Saprophytic  infection  (aspergilloma)
occurs in  patients  with  abnormal  airways  (chronic  obstructive  pulmonary  disease,  bronchiec-
tasis, cystic  ﬁbrosis)  or  chronic  lung  cavities.  Chronic  necrotizing  aspergillosis  (semi-invasive
form) is  described  in  patients  with  chronic  lung  pathology  or  mild  immunodeﬁciency.  Invasive
aspergillosis  (angio-invasive  or  broncho-invasive  forms)  occurs  in  severely  immuno-compromised
patients. Knowledge  of  the  various  radiological  patterns  for  each  form,  as  well  as  the  corre-
sponding  associated  immune  disorders  and/or  underlying  lung  diseases,  helps  early  recognition
and accurate  diagnosis.© 2015  Éditions  franc¸aises  de  radiologie.  Published  by  Elsevier  Masson  SAS.  All  rights  reserved.
Abbreviations: A. fumigatus,  Aspergillus fumigatus;  ABPA, allergic
monary disease; CF, cystic ﬁbrosis; HRCT, high-resolution computed tomog
lavage.
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Aspergillosis  is  a  mycotic  disease  caused  by  Aspergillus,
 ﬁlamentous  fungus.  The  most  common  pathogenic  species
esponsible  for  pulmonary  disease  is  Aspergillus  fumigatus
1].
A.  fumigatus  is  a  saprophytic  and  ubiquitous  airborne  fun-
us,  whose  natural  ecological  niche  is  the  soil  [1]. Heat,
oisture  and  organic  matters  (carpet,  autumn  leaves. .  .)
romote  its  development.
Humans  constantly  inhale  numerous  conidia  (spores)  of
his  fungus,  which  are  normally  eliminated  by  muco-ciliary
learance  and  innate  immune  mechanisms  in  immunocom-
etent  hosts  without  underlying  lung  disease  [1].
The  development  of  pulmonary  aspergillosis  requires
ost’s  predisposing  factors  such  as  allergic  status  (asthma),
irways  diseases  (bronchial  dilatation,  cystic  ﬁbrosis),
hronic  lung  cavities  (tuberculosis,  sarcoidosis. .  .) or
mmune  deﬁciency.
Allergic  reaction  to  Aspergillus  antigens  exposes  to
llergic  broncho-pulmonary  aspergillosis  (ABPA).  Alter-
tion  of  muco-ciliary  cells  in  bronchial  dilatation  or
ystic  ﬁbrosis  allows  colonization  of  the  airways  by
spergillus.  The  absence  of  macrophages  in  tuberculo-
is  cavity  and  other  chronic  lung  cavities  promotes  the
evelopment  of  a  ‘‘fungal  ball’’  (aspergilloma).  Immuno-
uppression  due  to  steroids,  transplantation,  or  aplasia
ay  be  responsible  for  chronic  necrotizing  forms  or
nvasive  forms  depending  on  the  level  of  immune  deﬁ-
iency.
Clinical,  radiological  and  histological  manifestations  of
ulmonary  aspergillosis  depend,  besides  the  number  and
irulence  of  the  spores,  mainly  on  the  immune  sta-
us  of  the  host  and  the  presence  of  pre-existing  lung
isease.
The  purpose  of  this  review  is  to  illustrate  the  radiologi-
al  appearance  of  the  four  categories  of  Aspergillus-related
ung  diseases  and  to  point  out,  for  each,  the  speciﬁc  immune
tatus  of  the  host.
spergillus fumigatus
.  fumigatus  is  a  saprophytic  and  ubiquitous  airborne  ﬁla-
entous  fungus,  whose  natural  ecological  niche  is  the  soil
1].  Its  development  is  favoured  by  some  contexts  such
s  heat,  moisture  and  organic  matters  (carpet,  autumn
eaves.  .  .).
The  conidia  released  into  the  atmosphere  have  a  diam-
ter  small  enough  (2  to  3  m)  to  reach  the  lung  alveoli
1].
The  concentration  of  spores  in  the  air  increases  with
onstruction  or  renovation  of  buildings  (levelling,  painting
epair.  . .) and  must  be  monitored  if  it  takes  place  in  hospi-
als.  Any  increase  in  the  concentration  of  airborne  conidia
aises  the  risk  of  contracting  aspergillosis  in  susceptible  indi-
iduals  [1].  Mycology  laboratories  and  haematology  services
re  equipped  with  hoods  and  laminar  ﬂow  to  avoid  aerial
ontamination.
There  are  other  sources  of  contamination,  less  known,
uch  as  spices  (pepper)  [2]  and  marijuana  [3],  which  contain
 lot  of  fumigatus  spores.
c
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arious presentations of pulmonary
spergillosis
llergic broncho-pulmonary aspergillosis
ABPA)
BPA  is  an  immunological  pulmonary  disorder  caused  by
ypersensitivity  to  Aspergillus  fumigatus  [4,5].
It  nearly  always  affects  asthmatics  (1—2%  of  asthma
atients)  or  patients  with  cystic  ﬁbrosis  (CF;  1—15%  of  CF
atients)  [6,7].
The  allergic  reaction  to  Aspergillus  antigens  is  respon-
ible  for  a  local  inﬂammatory  reaction  (with  inﬁltrate  of
osinophils,  excessive  mucus  production  and  bronchial  wall
amage)  and  an  airways’  ﬁlling  by  mucus  plugs,  containing
spergillus  and  eosinophils.  The  result  is  a  bronchial  dilata-
ion  typically  involving  segmental  and  subsegmental  bronchi
8],  with  predominance  in  the  upper  lung.
Clinical  manifestations  include  poorly  controlled  asthma,
heezing,  haemoptysis  and  productive  cough  with  expec-
oration  of  brownish  black  mucus  plugs.  However,  some
atients  can  remain  asymptomatic  [4,5].
CT  typically  demonstrates  the  presence  of  central
ronchiectasis,  usually  involving  segmental  or  subsegmental
ronchi,  with  upper  lobe  predominance.  These  bronchiec-
asis  are  ﬁlled  by  mucoid  impactions  with  an  inversed  Y
r  V  shape  and  are  also  called  ﬁnger-in-glove  opacities  [8]
Fig.  1).
High  attenuation  or  calciﬁcation  of  impacted  mucus  can
e  seen.  High  attenuation  mucus,  characterized  by  higher
ensity  than  that  of  paraspinal  muscles,  is  a  pathognomonic
nding  of  ABPA  [5].  Hyperattenuating  mucus  plugging  is
xplained  by  the  presence  of  calcium  salts  and  even  metals
the  ions  of  iron  and  manganese)  or  desiccated  mucus,  such
s  for  Aspergillus  sinusitis.
Occasionally,  lobar  or  segmental  atelectasis  may  occur.
arely,  pleural  effusion  or  spontaneous  pneumothorax  have
een  described.
If  untreated,  this  disease  can  evolve  to  pulmonary  ﬁbro-
is.
New  diagnostic  criteria  have  been  recently  proposed  to
mprove  the  accuracy  of  ABPA  diagnosis  [5].  These  criteria
nclude  predisposing  conditions  (bronchial  asthma  or  cystic
brosis)  associated  with  both  obligatory  criteria  and  at  least
wo  of  three  other  criteria.
Obligatory  criteria  are  type  I  Aspergillus  skin  test  posi-
ivity  (immediate  cutaneous  hypersensitivity  to  Aspergillus
ntigen)  or  elevated  levels  of  speciﬁc  IgE  against  Aspergillus
umigatus  and  elevated  total  IgE  levels  (>1000  IU/mL).  The
ther  three  criteria  are  presence  of  precipitating  or  IgG
ntibodies  against  A.  fumigatus  in  serum,  radiographic  pul-
onary  opacities  consistent  with  ABPA  and  total  eosinophil
ount  >500  cells/L  in  steroid  naive  patients.
The  chest  radiographic  features  consistent  with  ABPA
ay  be  transient  (i.e.  consolidation,  nodules,  tram-track
pacities,  toothpaste/ﬁnger-in-glove  opacities,  ﬂeeting
pacities)  or  permanent  (i.e.  parallel  line  and  ring  shadows,
ronchiectasis  and  pleuropulmonary  ﬁbrosis).High-resolution  computed  tomography  (HRCT)  of  the
hest  detects  abnormalities  not  apparent  on  chest  radio-
raph,  and  allows  better  assessment  of  the  pattern  and
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Figure 1. A 30-year-old asthmatic man with productive cough and dyspnea. Axial (a) and coronal (b, c) CT images show bilateral subseg-
mental bronchectasis ﬁlled with mucus (arrows). These images are called ﬁnger-in-glove opacities and are consistent with ABPA diagnosis.
); e: coronal CT image after treatment. Mucus plugging has disappeared
F
lOn mediastinal windowing (d), mucus plugs are hyperdense (102 HU
whereas bronchectasis persist (head arrow).
distribution  of  bronchiectasis,  HRCT  is  therefore  the  best
imaging  modality  for  evaluating  patients  with  suspected
ABPA  [5].
Saprophytic aspergillosis infection
(aspergilloma)
Saprophytic  aspergillosis  infection  is  due  to  Aspergillus  col-
onization  of  a  pre-existing  pulmonary  cavity  or  ectatic
bronchus.  It  combines  conglomerate  of  fungal  hyphae,
inﬂammatory  cells,  mucus  and  cellular  debris,  without  any
tissue  invasion  (Fig.  2).
This  infection  occurs  in  patients  with  abnormal  airways
(COPD,  bronchiectasis,  cystic  ﬁbrosis)  or  chronic  lung  cavi-
ties  such  as  tuberculous  caverns,  sarcoid-related  pulmonary
cavities,  emphysematous  bullae,  honeycomb  cysts. .  .).
Aspergilloma  is  characterized  by  the  presence  of  a  round
or  oval  mass  within  a  pulmonary  cavity,  typically  sur-
rounded  by  an  airspace,  resulting  in  the  ‘‘air  crescent’’
sign  (Figs.  3  and  4).  The  ‘‘fungus  ball’’  usually  moves  with
changes  in  position  [8,9].  The  degree  of  ﬁlling  of  the  lung
cavity  is  variable,  responsible  for  very  solid  forms  (pseudo-
tumoral)  and  very  cavitary  forms.  The  key  element  is  the
identiﬁcation  of  the  ‘‘air  crescent’’  sign,  for  which  CT
scan  is  more  effective  than  conventional  chest  radiography
(Figs.  3  and  4).
The  lack  of  ‘‘fungus  ball’’  into  a  cavity  does  not  exclude
aspergillosis  infection,  which  can  be  characterized  initially
by  an  isolated  wall  thickening.  All  chronic  lung  cavities
c
(
digure 2. Aspergilloma. Image of pathologic specimen after
obectomy showing a ‘‘fungus ball’’ within a cavity.an  be  colonized  by  Aspergillus  and  develop  aspergilloma
Fig.  5).
Saprophytic  aspergillosis  may  be  discovered  either  inci-
entally  or  after  an  episode  of  haemoptysis,  which  is
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Figure 3. Coronal (a) and sagittal (b) CT images showing pathognomonic aspergilloma: mass within a lung cavity surrounded by air, which
is called the ‘‘air crescent’’ sign. Aspergilloma cannot be diagnosed on chest X ray (c), because the air crescent sign is not visible.
Figure 4. a: tuberculosis sequelae in pulmonary apices on chest X ray; b and c: CT images demonstrate a fungus ball within a pulmonary
cavity in the left lower lung apex, which is pathognomonic for aspergilloma. Chest X ray only demonstrates bilateral opacities with retraction
of both lung apices.
Figure 5. a: axial CT image showing a broncho-pleural ﬁstula complicating left upper lobe resection; b: CT scan performed 1 year later
shows thickening of the cavity walls; c: two years later, a fungus ball with ‘‘air crescent’’ sign is demonstrated. All chronic lung cavities can
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he colonized by Aspergillus and develop aspergilloma. The ﬁrst sign
he  main  complication.  Aspergillomas  remain  stable  in  the
ajority  of  cases,  but  can  also  decrease  in  size  or  even  spon-
aneously  resolve  in  about  10%  of  cases.  Aspergillomas  more
arely  show  size  increase  [10].
Other  causes  of  ‘‘air  crescent’’  sign  include  angio-
nvasive  and  chronic  necrotizing  aspergillosis.  In  these  cases,
here  are  no  pre-existing  cavities;  radiological  manifesta-
ions  appear  within  a  few  days  in  the  angio-invasive  forms
nd  within  several  weeks  or  months  in  the  chronic  necrotiz-
ng  forms  [11]  (Fig.  6).
d
whe saprophytic infection is usually a thickening of the cavity walls.
hronic necrotizing aspergillosis (former
emi-invasive form)
hronic  necrotizing  aspergillosis  (CNA)  is  a  rare  and
oorly  understood  form  of  aspergillosis,  which  can
imic  other  chronic  pulmonary  infections  (tuberculosis,
istoplasmosis.  .  .). Its  recognition  and  diagnosis  are  often
elayed.
CNA  is  a  locally  invasive  disease  that  occurs  in  patients
ith  chronic  lung  pathology  [12]  or  mild  immunodeﬁciency
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Figure 6. ‘‘Air crescent’’ sign. Axial CT images of 3 different patients, showing a lung parenchyma opacity surrounded by an ‘‘air crescent’’
sign. This feature is not speciﬁc of saprophytic infection (aspergilloma; a), it can be seen in semi-invasive aspergillosis (chronic necrotizing
aspergillosis; b) and in invasive aspergillosis (c). In the latter two cases (b and c), there was not any pre-existing lung cavity; the focal area
of necrosis is due to fungal invasion.
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ure,  COPD. .  .
Radiologically,  CNA  is  characterized  by  pulmonary
consolidations,  usually  involving  the  upper  lobes,  with
bronchiectasis.  The  consolidation  progresses  with  time  to
cavitation  over  weeks  to  months  [12,13].
As  indicated  earlier,  a  ‘‘fungal  ball’’  with  ‘‘air  crescent
sign’’  may  develop  in  CNA  as  a  secondary  phenomenon  due
to  the  parenchymal  destruction  by  the  fungus  [11]  (Fig.  7).
In  2003,  Denning  et  al.  proposed  diagnostic  criteria  for
CNA  [14]  (Boxed  text).
Boxed  text:  Denning’s  criteria  [14]  for  chronic
necrotizing  aspergillosis.
• Chronic  pulmonary  or  systemic  symptoms  (duration
3  months)  compatible  with  CPA,  including  at  least  1
of  the  following  symptoms:  weight  loss,  productive
cough,  or  haemoptysis.
• Cavitary  pulmonary  lesion  with  evidence  of
paracavitary  inﬁltrates,  new  cavity  formation,
or  expansion  of  cavity  size  over  time.
• Either  positive  result  of  serum  Aspergillus  precipitins
test  or  isolation  of  Aspergillus  spp.  from  pulmonary
or  pleural  cavity.
• Elevated  levels  of  inﬂammatory  markers  (C-
reactive  protein,  plasma  viscosity,  or  erythrocyte
sedimentation  rate).
• Exclusion  of  other  pulmonary  pathogens,  by  results
of  appropriate  cultures  and  serological  tests,  that
are  associated  with  similar  disease  presentation,
including  mycobacteria  and  endemic  fungi
(especially  Coccidioides  immitis  and  Histoplasma
capsulatum).
• No overt  immunocompromising  conditions  (e.g.,
HIV  infection,  leukemia,  and  chronic  granulomatous
disease).
t
e
nnvasive aspergillosis: angio-invasive and
irway-invasive forms
nvasive  pulmonary  aspergillosis  is  an  aggressive  disease  due
o  the  invasion  of  the  bronchial  wall  and  the  accompany-
ng  arterioles  by  the  hyphae.  This  form  primarily  occurs  in
everely  immuno-compromised  patients,  especially  patients
ith  neutropenia  due  to  allogenic  bone  marrow  transplan-
ation  or  chemotherapy  for  acute  leukemia  [15],  but  also
atients  who  received  solid-organ  transplantation,  espe-
ially  lung  transplantation  [16].
The  most  important  risk  factor  is  neutropenia.  The  risk  of
nvasive  aspergillosis  is  strongly  correlated  with  the  duration
nd  degree  of  neutropenia  [11].
Symptoms  are  non-speciﬁc  and  usually  mimic  bron-
hopneumonia,  but  also  include  pleuritic  chest  pain  and
aemoptysis  [11].
Invasive  aspergillosis  is  a  diagnostic  and  therapeutic  chal-
enge  due  to  the  high  morbidity  and  mortality.
There  are  two  sub-categories  of  invasive  aspergillosis,
he  airway-invasive  form  and  the  angio-invasive  form.
The  airway-invasive  form  accounts  for  15  to  30%  of
nvasive  aspergillosis,  and  is  deﬁned  by  the  presence  of
spergillus  deep  to  the  basal  membrane  of  the  bronchi  [17].
Radiologically,  it  can  mimic  bronchiolitis  with  patchy  cen-
rilobular  nodules  with  tree-in-bud  appearance,  similar  to
hose  seen  in  endobronchial  spread  of  tuberculosis.  A  bron-
hopneumonia  presentation  is  common,  with  conﬂuence  of
eribronchial  consolidations,  similar  to  bacterial  bronchop-
eumonia  [8,17]  (Fig.  8).
In rare  cases,  the  fungal  infection  is  entirely  or  pre-
ominantly  conﬁned  to  the  tracheobronchial  tree.  Acute
spergillus  tracheobronchitis  usually  occurs  in  lung  trans-
lantation  recipients  [16]. Radiologically,  it  may  appear  as
racheal  or  bronchial  irregular  wall  thickening,  with  occa-
ionally  high  attenuation  aspect  due  to  ability  of  Aspergillus
o  ﬁx  calcium.  Atelectasis  or  endobronchial  masses  have
ven  been  described.  However,  most  of  the  time,  there  are
o  detectable  radiological  abnormalities  [8,18].
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Figure 7. Chronic necrotizing aspergillosis; a and b: axial CT images showing a right upper lobe consolidation with bronchectasis; c and
d: correspond to CT images of the same patient 5 months (c) and 7 months (d) latter. Progressive cavitation of the initial consolidation is
seen; e and f: are chest radiographs corresponding to CT scans images c and d. They show a progressive cavitation of the right upper lobe.
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comparison with the ﬁrst available chest X ray is crucial, to detec
ource of delayed diagnosis.
The  angio-invasive  form  is  histologically  characterized
y  the  invasion  and  occlusion  of  small  to  medium-size
ulmonary  arteries  by  fungal  hyphae  [8].  Typical  CT  ﬁnd-
ngs  [8,17]  consist  in  larges  nodules  surrounded  by  ground
lass  attenuation,  which  is  called  the  ‘‘halo  sign’’.  Nod-
les  are  due  to  coagulation  necrosis,  whereas  the  halo
f  ground  glass  is  due  to  surrounding  alveolar  haemorr-
age  [19]  (Fig.  9).  Other  ﬁndings  are  pleura-based  areas  of
H
u
s
igure 8. Broncho-invasive aspergillosis in a 50-year-old man with allo
ilateral lobular consolidation with centrilobular nodules in the left low
ould also be due to bacterial bronchopneumonia. progressive cavitation because changes occur slowly, which is the
onsolidation,  similar  to  those  seen  in  pulmonary  infarcts
omplicating  pulmonary  embolism,  correspond  to  haemor-
hagic  infarcts.
Differential  diagnoses  of  ‘‘halo  sign’’  in  neu-
ropenic  patients  include  infections  due  to  Candida,
erpes  simplex  and  cytomegalovirus,  Wegener  gran-
lomatosis,  haemorrhagic  metastases  and  Kaposi
arcoma.
genic bone marrow transplantation. Axial CT images (a, b) showing
er lobe (b). These features are non-speciﬁc of fungal infection and
Pulmonary  aspergillosis  
Figure 9. Angio-invasive aspergillosis in a 31-year-old-woman
with lung transplantation. Axial CT image showing a large nod-
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bule in the right lower lobe surrounded by a halo of ground glass
attenuation (halo sign).
The  occurrence  of  cavitation  within  a  nodule  or  a
consolidation  is  often  concomitant  with  the  resolution  of
neutropenia.  In  this  late  phase,  the  separation  of  the
necrotic  lung  fragment  from  the  adjacent  lung  parenchyma
results  in  an  ‘‘air  crescent’’  sign  similar  to  that  observed  in
aspergilloma.  Unlike  saprophytic  aspergillosis  infection,  the
opacity  surrounded  by  a  crescent  airspace  develops  in  less
than  2  weeks  and  without  pre-existing  cavity  (Fig.  10).
Therefore,  it  is  essential  to  think  in  terms  of  immunolog-
ical  status  and  fastness  of  evolution  in  case  of  cavitation.
There  are  increasing  numbers  of  reports  documenting
invasive  aspergillosis  in  immunocompetent  patients  with
severe  COPD,  often  with  prolonged  use  of  corticosteroid
therapy  [11].
Overlap between these various manifestations
Beyond  this  segmentation  in  four  forms  it  should  be  noted
that  an  overlap  between  the  main  categories  of  Aspergillus-
related  diseases  has  been  reported.  Some  forms  could
co-exist,  especially  allergic  broncho-pulmonary  aspergillosis
and  aspergilloma  [11,20].Changes  of  local  or  systemic  host  immunity  and  of  under-
lying  lung  pathology  can  modify  aspergillosis  pulmonary
manifestations  with  time.  For  example,  an  aspergilloma  can
develop  within  bronchiectasis  in  a  patient  with  ABPA.  An
B
B
a
Figure 10. a: axial CT image in a leukemia patient showing a right upp
c: axial and coronal CT images acquired 3 weeks later showing an ‘‘air cr
aspergilloma but is relevant to a necrotic lung fragment in an angio-inva441
nvasive  form  can  complicate  long-standing  ABPA  in  case  of
ystemic  immune  deﬁciency,  including  the  use  of  high-dose
f  steroids  [20].
ycological diagnosis: which sample
llows diagnosis?
putum
irect  examination  can  be  made  to  identify  the  presence  of
laments.
The  signiﬁcance  of  isolating  Aspergillus  in  sputum  sam-
les  depends  on  the  immune  status  of  the  host.  In
mmunocompetent  patients,  it  represents  at  least  a  colo-
ization,  while  it  is  highly  predictive  of  invasive  disease
n  immuno-compromised  patients  [11]. Conversely,  negative
putum  samples  do  not  rule  out  aspergillosis,  including  inva-
ive  forms  [11].  The  results  of  cultures  are  often  delayed.
erum
etection  of  IgG  antibodies  against  A.  fumigatus  in  the
erum  helps  the  diagnosis  of  aspergilloma  or  ABPA,  the  two
orms  of  aspergillosis  observed  in  immunocompetent  indi-
iduals  [1].  It  can  be  negative  in  patients  on  corticosteroid
herapy.
In  contrast  to  immunocompetent  hosts,  growth  of
.  fumigatus  in  the  tissues  of  an  immunosuppressed  host  is
ot  correlated  with  an  increase  in  anti-Aspergillus  antibody
iters  [1].  Consequently,  detection  of  Aspergillus  antigens  in
he  serum  is  more  useful  for  diagnosing  invasive  aspergillosis
n  immuno-compromised  patients  (ELISA,  latex  agglutina-
ion).  Galactomannan  is  the  most  commonly  used  antigen,
t  is  a  polysaccharide  fungal  cell  wall  component  released
uring  hyphal  growth  in  tissues.  It  is  reported  that  serum
alactomannan  can  be  detected  several  days  before  the
resence  of  clinical  symptoms,  chest  radiographic  abnor-
alities  or  positive  culture  [11].
Another  possibility  is  the  detection  of  A.  fumigatus  DNA
y  PCR.ronchoalveolar lavage (BAL)
AL  is  useful  to  identify  Aspergillus  by  direct  examination
nd  culture.
er lobe nodule surrounded by mild ground glass attenuation; b and
escent’’ sign surrounding a focal opacity. This feature is similar to
sive form of aspergillosis.
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coincident forms. Eur Radiol 2003;13(8):1786—800.42  
Further,  as  for  serum,  Aspergillus  antigens  (galactoman-
an)  and  A.  fumigatus  DNA  (by  PCR)  can  be  detected  in  BAL
21].
iopsy
he  histopathological  examination  of  lung  tissue  with  posi-
ive  culture  is  the  gold  standard  for  the  diagnosis  of  invasive
spergillosis  [11].  Nevertheless,  surgical  biopsies  are  infre-
uently  performed,  only  for  diagnosis  purposes  in  fragile
atients.
onclusion
he  spectrum  of  respiratory  diseases  caused  by  Aspergillus
s  wide.  It  includes  hypersensitivity  in  ABPA,  saprophytic
nfection  in  pre-existing  broncho-pulmonary  diseases  and
emi-invasive  or  invasive  forms  in  immuno-compromised
atients.
The  correlation  between  the  immunologic  status  of  the
ost,  an  essential  factor  in  the  occurrence  of  Aspergillus-
elated  lung  diseases,  and  the  radiological  presentation  is  of
ajor  importance  for  accurate  diagnosis  of  these  diseases.
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